151 related articles for article (PubMed ID: 28356151)
1. Endothelial dysfunction in the pathogenesis of pre-eclampsia in Ghanaian women.
Adu-Bonsaffoh K; Antwi DA; Gyan B; Obed SA
BMC Physiol; 2017 Mar; 17(1):5. PubMed ID: 28356151
[TBL] [Abstract][Full Text] [Related]
2. Assessment of angiogenesis modulators in pregnant women with pre-eclampsia: a case-control study.
Mundim GJ; Paschoini MC; Araujo Júnior E; Da Silva Costa F; Rodrigues Júnior V
Arch Gynecol Obstet; 2016 Feb; 293(2):369-75. PubMed ID: 26205065
[TBL] [Abstract][Full Text] [Related]
3. Circulating angiogenic factors in pregnancies complicated by pre-eclampsia.
Varughese B; Bhatla N; Kumar R; Dwivedi SN; Dhingra R
Natl Med J India; 2010; 23(2):77-81. PubMed ID: 20925202
[TBL] [Abstract][Full Text] [Related]
4. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
Cheng M; He P; Fu J
J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
[TBL] [Abstract][Full Text] [Related]
5. Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia.
Bills VL; Varet J; Millar A; Harper SJ; Soothill PW; Bates DO
Clin Sci (Lond); 2009 Feb; 116(3):265-72. PubMed ID: 18826376
[TBL] [Abstract][Full Text] [Related]
6. Placental lesions and differential expression of pro-and anti-angiogenic growth mediators and oxidative DNA damage marker in placentae of Ghanaian suboptimal and optimal health status pregnant women who later developed preeclampsia.
Anto EO; Coall DA; Asiamah EA; Afriyie OO; Addai-Mensah O; Wiafe YA; Owiredu W; Obirikorang C; Annani-Akollor ME; Titiloye NA; Adua E; Acheampong E; Adu EA; Opoku S; Anto AO; Tawiah A; Wang Y; Wang W
PLoS One; 2022; 17(3):e0265717. PubMed ID: 35312727
[TBL] [Abstract][Full Text] [Related]
7. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
8. Alteration in maternal serum uric acid levels in pre-eclampsia and associated perinatal outcomes: a cross-sectional study in Ghana.
Adu-Bonsaffoh K; Kudaya DQ; Fidelis B; Fondjo LA; Ahenkorah J
Pan Afr Med J; 2024; 47():49. PubMed ID: 38681101
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and endothelin-1 levels in normal pregnant women and pregnant women with pre-eclampsia.
Celik H; Avci B; Işik Y
J Obstet Gynaecol; 2013 May; 33(4):355-8. PubMed ID: 23654314
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of angiogenic factors and their association with preeclampsia among pregnant women at Mulago National Referral Hospital in Uganda.
Nabweyambo S; Sande OJ; McGovern N; Bwanga F; Ssekagiri A; Keesiga A; Adroma M; Wasswa R; Atuheirwe M; Namugenyi J; Castelnuovo B; Nakimuli A
PLoS One; 2021; 16(5):e0251227. PubMed ID: 34010327
[TBL] [Abstract][Full Text] [Related]
11. Uteroplacental blood flow and placental vascular endothelial growth factor in normotensive and pre-eclamptic pregnancy.
Simmons LA; Hennessy A; Gillin AG; Jeremy RW
BJOG; 2000 May; 107(5):678-85. PubMed ID: 10826585
[TBL] [Abstract][Full Text] [Related]
12. The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia.
Govender L; Mackraj I; Gathiram P; Moodley J
Cardiovasc J Afr; 2012 Apr; 23(3):153-9. PubMed ID: 22555639
[TBL] [Abstract][Full Text] [Related]
13. Identification of vascular endothelial growth factor in preeclampsia in Iraqi women.
Al-Ghazali B; Khadim M; Hamza S; Al-Haddad HS; Jumaah AS; Hadi N
J Med Life; 2022 Oct; 15(10):1252-1256. PubMed ID: 36420291
[TBL] [Abstract][Full Text] [Related]
14. ASSESSMENT OF OXIDATIVE STRESS IN EARLY AND LATE ONSET PRE-ECLAMPSIA AMONG GHANAIAN WOMEN.
Tetteh PW; Adu-Bonsaffoh K; Antwi-Boasiako C; Antwi DA; Gyan B; Obed SA
J West Afr Coll Surg; 2015; 5(1):42-58. PubMed ID: 27182519
[TBL] [Abstract][Full Text] [Related]
15. Comparison of angiogenic and anti-angiogenic factors in maternal and umbilical cord blood in early- and late-onset pre-eclampsia.
Sezer SD; Küçük M; Yenisey C; Yüksel H; Odabaşı AR; Türkmen MK; Çetinkaya Çakmak B; Ömürlü IK
Gynecol Endocrinol; 2012 Aug; 28(8):628-32. PubMed ID: 22429154
[TBL] [Abstract][Full Text] [Related]
16. Effect of vascular endothelial growth factors A, C, and D in HIV-associated pre-eclampsia.
Shange GP; Moodley J; Naicker T
Hypertens Pregnancy; 2017 May; 36(2):196-203. PubMed ID: 28524736
[TBL] [Abstract][Full Text] [Related]
17. VEGF and its soluble receptor VEGFR-2 in hypertensive disorders during pregnancy: the Indian scenario.
Rath G; Tripathi R
J Hum Hypertens; 2012 Mar; 26(3):196-204. PubMed ID: 21412269
[TBL] [Abstract][Full Text] [Related]
18. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia.
Lyall F; Greer IA; Boswell F; Fleming R
Br J Obstet Gynaecol; 1997 Feb; 104(2):223-8. PubMed ID: 9070144
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum irisin levels in early and late-onset pre-eclamptic and healthy pregnancies.
Ozel A; Davutoglu EA; Firat A; Erenel H; Karslı MF; Korkmaz SÖ; Madazli R
J Obstet Gynaecol; 2018 Jul; 38(5):642-646. PubMed ID: 29430974
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor (VEGF)-634G/C polymorphism was associated with severe pre-eclampsia and lower serum VEGF level.
Salimi S; Yaghmaei M; Tabatabaei E; Mokhtari M; Naghavi A
J Obstet Gynaecol Res; 2015 Dec; 41(12):1877-83. PubMed ID: 26486233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
